Gender differences in serum high-molecular-weight adiponectin levels in metabolic syndrome

European Journal of Endocrinology

Volumn 168, Issue 3, 2013, Pages 385-391

  Eglit, Triin ^a   Lember, Margus ^a   Ringmets, Inge ^a   Rajasalu, Tarvo ^a  

^a UNIVERSITY OF TARTU   (Estonia)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MOLECULAR WEIGHT; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SEX DIFFERENCE;

ADIPONECTIN; ADULT; AGED; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; ESTONIA; FEMALE; GENERAL PRACTICE; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; METABOLISM, INBORN ERRORS; MIDDLE AGED; MOLECULAR WEIGHT; PREVALENCE; PROTEIN PRECURSORS; SENSITIVITY AND SPECIFICITY; SEX CHARACTERISTICS; YOUNG ADULT;

EID: 84874024963     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-12-0688     Document Type: Article

References (30)

1. Alberti KG, Eckel RH, Grundy S.M., Zimmet PZ, Cleeman JI, Donato KA, Fruchart J.C., James WP, Loria CM, Smith SC et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009 120 1640-1645. (doi:10.1161/CIRCULATIONAHA.109.192644)
2. Eckel RH, Grundy SM & Zimmet PZ. The metabolic syndrome. Lancet 2005 365 1415-1428. (doi:10.1016/S0140-6736(05) 66378-7)
3. Mottillo S, Filion KB, Genest J, Joseph L., Pilote L, Poirier P, Rinfret S., Schiffrin EL & Eisenberg MJ. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. Journal of the American College of Cardiology 2010 56 1113-1132. (doi:10.1016/j.jacc.2010.05.034)
4. Cornier MA, Dabelea D, Hernandez T.L., Lindstrom RC, Steig AJ, Stob NR, Van Pelt RE, Wang H & Eckel RH. The metabolic syndrome. Endocrine Reviews 2008 29 777-822. (doi:10.1210/er. 2008-0024)
5. Grundy SM, Cleeman JI, Daniels S.R., Donato KA, Eckel RH, Franklin BA, Gordon D.J., Krauss RM, Savage PJ, Smith SC et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005 112 2735-2752. (doi:10.1161/CIRCULATIONAHA.105.169404)
6. Eglit T, Rajasalu T & Lember M. Metabolic syndrome in Estonia: prevalence and associations with insulin resistance. International Journal of Endocrinology 2012 2012 951672. (doi:10.1155/2012/951672)
7. Rabe K, Lehrke M, Parhofer KG & Broedl UC. Adipokines and insulin resistance. Molecular Medicine 2008 14 741-751. (doi:10.2119/2008-00058.Rabe)
8. Tilg H & Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nature Reviews. Immunology 2006 6 772-783. (doi:10.1038/nri1937)
9. Hirose H, Yamamoto Y, Seino-Yoshihara Y, Kawabe H & Saito I. Serum high-molecular-weight adiponectin as a marker for the evaluation and care of subjects with metabolic syndrome and related disorders. Journal of Atherosclerosis and Thrombosis 2010 17 1201-1211. (doi:10.5551/jat.6106)
10. Zhu N, Pankow J, Ballantyne C., Couper D, Hoogeveen R, Pereira M., Duncan B & Schmidt M. High-molecular-weight adiponectin and the risk of type 2 diabetes in the ARIC study. Journal of Clinical Endocrinology and Metabolism 2010 95 5097-5104. (doi:10.1210/jc.2010-0716)
11. Snijder M, Heine R, Seidell J., Bouter L, Stehouwer C, Nijpels G., Funahashi T, Matsuzawa Y, Shimomura I & Dekker J. Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women - the Hoorn study. Diabetes Care 2006 29 2498-2503. (doi:10.2337/dc06-0952)
12. Cook JR & Semple RK. Hypoadiponectinemia - cause or consequence of human "insulin resistance"? Journal of Clinical Endocrinology and Metabolism 2010 95 1544-1554. (doi:10.1210/jc.2009-2286)
13. Fisher FM, Trujillo ME, Hanif W, Barnett A.H., McTernan PG, Scherer PE & Kumar S. Serum high molecular weight complex of adiponectin correlates better with glucose tolerance than total serum adiponectin in Indo-Asian males. Diabetologia 2005 48 1084-1087. (doi:10.1007/s00125-005-1758-7)
14. Hara K, Horikoshi M, Yamauchi T., Yago H, Miyazaki O, Ebinuma H., Imai Y, Nagai R & Kadowaki T. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 2006 29 1357-1362. (doi:10.2337/dc05-1801)
15. Kawamoto R, Tabara Y, Kohara K., Miki T, Kusunoki T, Takayama S., Abe M, Katoh T & Ohtsuka N. Relationships between lipid profiles and metabolic syndrome, insulin resistance and serum high molecular adiponectin in Japanese community-dwelling adults. Lipids in Health and Disease 2011 10 79. (doi:10.1186/1476-511X-10-79)
16. Yu D, Yu Z, Sun Q., Sun L, Li H, Song J., Mi M, Wu H, Lu L., Liu C et al. Effects of body fat on the associations of high-molecular-weight adiponectin, leptin and soluble leptin receptor with metabolic syndrome in Chinese. PLoS ONE 2011 6 e16818. (doi:10.1371/journal.pone.0016818)
17. Liu Y, Retnakaran R, Hanley A., Tungtrongchitr R, Shaw C & Sweeney G. Total and high molecular weight but not trimeric or hexameric forms of adiponectin correlate with markers of the metabolic syndrome and liver injury in Thai subjects. Journal of Clinical Endocrinology and Metabolism 2007 92 4313-4318. (doi:10.1210/jc.2007-0890)
18. Lee JM, Kim SR, Yoo S.J., Hong OK, Son HS & Chang SA. The relationship between adipokines, metabolic parameters and insulin resistance in patients with metabolic syndrome and type 2 diabetes. Journal of International Medical Research 2009 37 1803-1812.
19. Devaraj S, Swarbrick MM, Singh U, Adams-Huet B, Havel PJ & Jialal I. CRP and adiponectin and its oligomers in the metabolic syndrome: evaluation of new laboratory-based biomarkers. American Journal of Clinical Pathology 2008 129 815-822. (doi:10.1309/RN84K51B2JJY1Y0B)
20. Khan UI, Wang D, Sowers M.R., Mancuso P., Everson-Rose SA, Scherer PE & Wildman RP. Race-ethnic differences in adipokine levels: the Study of Women's Health Across the Nation (SWAN). Metabolism 2012 61 1261-1269. (doi:10.1016/j.metabol.2012. 02.005)
21. Nishizawa H, Shimomura I, Kishida K., Maeda N, Kuriyama H, Nagaretani H., Matsuda M, Kondo H, Furuyama N., Kihara S et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 2002 51 2734-2741. (doi:10.2337/diabetes.51.9.2734)
22. Wang Y, Lam KS, Yau MH & Xu A. Post-translational modifications of adiponectin: mechanisms and functional implications. Biochemical Journal 2008 409 623-633. (doi:10.1042/BJ20071492)
23. Ahonen T, Saltevo J, Laakso M., Kautiainen H, Kumpusalo E & Vanhala M. Gender differences relating to metabolic syndrome and proinflammation in Finnish subjects with elevated blood pressure. Mediators of Inflammation 2009 2009 959281. (doi:10.1155/2009/959281)
24. Rathmann W, Haastert B, Herder C., Hauner H, Koenig W, Meisinger C., Holle R & Giani G. Differential association of adiponectin with cardiovascular risk markers in men and women? The KORA survey 2000. International Journal of Obesity 2007 31 770-776.
25. Nakashima R, Yamane K, Kamei N., Nakanishi S & Kohno N. Low serum levels of total and high-molecular-weight adiponectin predict the development of metabolic syndrome in Japanese-Americans. Journal of Endocrinological Investigation 2011 34 615-619. (doi:10.3275/7409)
26. Jürimäe J & Jürimäe T. Plasma adiponectin concentration in healthy pre-and postmenopausal women: relationship with body composition, bone mineral, and metabolic variables. American Journal of Physiology. Endocrinology and Metabolism 2007 293 E42-E47. (doi:10.1152/ajpendo. 00610.2006)
27. Jürimäe T, Jürimäe J, Leppik A, Tafeit E & Kums T. Relationships between adiponectin, leptin, and blood lipids in physically active postmenopausal females. American Journal of Human Biology 2010 22 609-612. (doi:10.1002/ajhb.21052)
28. Ren J & Kelley RO. Cardiac health in women with metabolic syndrome: clinical aspects and pathophysiology. Obesity 2009 17 1114-1123. (doi:10.1038/oby.2009.8)
29. Pischon T, Hu FB, Rexrode K.M., Girman CJ, Manson JE & Rimm EB. Inflammation, the metabolic syndrome, and risk of coronary heart disease in women and men. Atherosclerosis 2008 197 392-399. (doi:10.1016/j.atherosclerosis. 2007.06.022)
30. Schillaci G, Pirro M, Pucci G., Mannarino MR, Gemelli F, Siepi D, Vaudo G & Mannarino E. Different impact of the metabolic syndrome on left ventricular structure and function in hypertensive men and women. Hypertension 2006 47 881-886. (doi:10.1161/01.HYp.0000216778.83626.39)